BenevolentAI announced the appointment of Catherine Isted, ACMA, who will be joining the Company as Chief Financial Officer (CFO) with immediate effect. Catherine is an experienced strategic finance professional and chartered accountant with over 25 years within the life sciences industry. She was most recently Chief Executive Officer of ReNeuron, having previously been CFO.

Prior to this, she was at Oxford Biomedica plc, at a time of significant growth for the company, where as part of the finance leadership team, she headed up Corporate Development and Investor Relations as well as worked with the Board on various strategic projects. Previously, Catherine had a successful career in leading healthcare banking teams, 12 years of which at Partner level, holding research analyst and equity sales positions at Morgan Stanley, ABN AMRO, Nomura and Peel Hunt. She started her career as a bench scientist at Merck Sharp & Dohme (MSD), before moving into their finance department as an accountant.

Catherine holds a first-class Chemistry degree and is a qualified Chartered Management Accountant.